AnserBio
Israel
unknownunknown
unknown
Stage
2020
Founded
1
Investors
About
AnserBio develops an oncology therapeutic delivery platform using exosomes to deliver healthy p53 protein for restoring tumor suppression in cancers with TP53 gene mutations.
Explore AnserBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.